Cell pyroptosis, a pro-inflammatory programmed cell death, plays a critical role in atherosclerosis (As) pathogenesis. Our previous studies have shown that theaflavin (TF), a polyphenolic compound, exhibits antioxidant and anti-inflammatory properties and can alleviate the progression of As. However, its impact on macrophage pyroptosis in As remains unexplored. Here, we investigated the effect of TF on pyroptosis in macrophages stimulated by oxidized low-density lipoprotein (ox-LDL). Our results demonstrated that TF significantly inhibited pyroptosis by suppressing the activation of caspase-1, reducing the cleavage of Gasdermin D (GSDMD), and downregulating the expression of NLRP3, interleukin-1β (IL-1β), and interleukin-1α (IL-1α). Additionally, TF decreased the production of reactive oxygen species (ROS), indicating its antioxidant role in mitigating pyroptosis. To verify whether the inhibitory effect of TF on pyroptosis is mediated by reducing ROS, we conducted experiments using N-acetylcysteine (NAC), a specific ROS inhibitor. We set up five groups: control group, ox-LDL group, ox-LDL + TF group, ox-LDL + NAC group, and ox-LDL + TF + NAC group. RT-qPCR detection revealed that the mRNA levels of pyroptosis-related genes in the ox-LDL + NAC group were significantly reduced, and the reduction was more pronounced in the ox-LDL + TF + NAC group, showing a synergistic effect between TF and NAC. These findings highlight that TF holds promise as a therapeutic agent for As by targeting oxidative stress and pyroptosis pathways.

Wen Guo, Zihan Luo, Jing Xiang. Theaflavin Attenuation of Atherosclerotic Inflammation via Regulation of Macrophage Pyroptosis Signaling Pathway. Frontiers in Medical Science Research (2025), Vol. 7, Issue 4: 109-115. https://doi.org/10.25236/FMSR.2025.070414.

[1] Riksen N P, Bekkering S, Mulder W, et al. Trained immunity in atherosclerotic cardiovascular disease[J]. Nat Rev Cardiol, 2023,20(12):799-811.

[2] Poznyak A, Grechko A V, Poggio P, et al. The Diabetes Mellitus-Atherosclerosis Connection: The Role of Lipid and Glucose Metabolism and Chronic Inflammation[J]. Int J Mol Sci, 2020,21(5).

[3] Tian M, Zhao J, Mi X, et al. Progress in research on effect of PM(2.5) on occurrence and development of atherosclerosis[J]. J Appl Toxicol, 2021,41(5):668-682.

[4] Aarup A, Pedersen T X, Junker N, et al. Hypoxia-Inducible Factor-1α Expression in Macrophages Promotes Development of Atherosclerosis[J]. Arterioscler Thromb Vasc Biol, 2016,36(9):1782-1790.

[5] Wang N C, Matthews K A, Barinas-Mitchell E J, et al. Inflammatory/hemostatic biomarkers and coronary artery calcification in midlife women of African-American and White race/ethnicity: the Study of Women's Health Across the Nation (SWAN) heart study[J]. Menopause, 2016,23(6):653-661.

[6] Wang S, Yuan Y H, Chen N H, et al. The mechanisms of NLRP3 inflammasome/pyroptosis activation and their role in Parkinson's disease[J]. Int Immunopharmacol,2019,67:458-464.

[7] Kesavardhana S, Malireddi R, Kanneganti T D. Caspases in Cell Death, Inflammation, and Pyroptosis[J]. Annu Rev Immunol,2020,38:567-595.

[8] Shi J, Zhao Y, Wang K, et al. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death[J]. Nature,2015,526(7575):660-665.

[9] Jiang X, Ma C, Gao Y, et al. Tongxinluo attenuates atherosclerosis by inhibiting ROS/NLRP3/caspase-1-mediated endothelial cell pyroptosis[J]. J Ethnopharmacol,2023,304:116011.

[10] Wang Y, Shi P, Chen Q, et al. Mitochondrial ROS promote macrophage pyroptosis by inducing GSDMD oxidation[J]. J Mol Cell Biol,2019,11(12):1069-1082.

[11] Yang Y, Liu P Y, Bao W, et al. Hydrogen inhibits endometrial cancer growth via a ROS/NLRP3/caspase-1/GSDMD-mediated pyroptotic pathway[J]. BMC Cancer,2020,20(1):28.

[12] Huang Y, Gao C, Song W, et al. Improving Theaflavin-3,3'-digallate Production Efficiency Optimization by Transition State Conformation of Polyphenol Oxidase[J]. Molecules,2023,28(9).

[13] Peluso I, Serafini M. Antioxidants from black and green tea: from dietary modulation of oxidative stress to pharmacological mechanisms[J]. Br J Pharmacol,2017,174(11):1195-1208.

[14] Fang Y, Wang J, Cao Y, et al. The Antiobesity Effects and Potential Mechanisms of Theaflavins[J]. J Med Food,2024,27(1):1-11.

[15] Mo L, Ma C, Wang Z, et al. Integrated Bioinformatic Analysis of the Shared Molecular Mechanisms Between Osteoporosis and Atherosclerosis[J]. Front Endocrinol (Lausanne),2022,13:950030.

[16] Hou P, Fang J, Liu Z, et al. Macrophage polarization and metabolism in atherosclerosis[J]. Cell Death Dis,2023,14(10):691.

[17] Swirski F K, Pittet M J, Kircher M F, et al. Monocyte accumulation in mouse atherogenesis is progressive and proportional to extent of disease[J]. Proc Natl Acad Sci U S A,2006,103(27):10340-10345.

[18] Tabas I. Consequences and therapeutic implications of macrophage apoptosis in  atherosclerosis: the importance of lesion stage and phagocytic efficiency[J]. Arterioscler Thromb Vasc Biol,2005,25(11):2255-2264.

[19] Wu Y, Chen M, Chen Z, et al. Theaflavin-3,3'-Digallate from Black Tea Inhibits Neointima Formation Through Suppression of the PDGFRβ Pathway in Vascular Smooth Muscle Cells[J]. Front Pharmacol,2022,13:861319.

[20] Cheng Y C, Chu L W, Chen J Y, et al. Loganin Attenuates High Glucose-Induced Schwann Cells Pyroptosis by Inhibiting ROS Generation and NLRP3 Inflammasome Activation[J]. Cells,2020,9(9).